For instance, greater phosphorylation at the serine 637 site, indicative of DRP1 inhibition, was observed in early symptomatic SMA mice before significant muscle atrophy has occurred, whereas a shift towards enhanced expression of the serine 616 activation mark was noted at P21 during the peak atrophic phenotype. Here, SMN1 is linked to Atrophy.